Cargando…
Risk-based decision-making related to preprocedural coronavirus disease 2019 testing in the setting of GI endoscopy: management of risks, evidence, and behavioral health economics
BACKGROUND AND AIMS: Controversies exist regarding the benefits and most appropriate approach for preprocedural coronavirus disease 2019 (COVID-19) testing (eg, rapid antigen test, polymerase chain reaction, or real-time polymerase chain reaction) for outpatients undergoing diagnostic and therapeuti...
Autores principales: | Moy, Naomi, Dulleck, Uwe, Shah, Ayesha, Messmann, Helmut, Thrift, Aaron P., Talley, Nicholas J., Holtmann, Gerald J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American Society for Gastrointestinal Endoscopy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174097/ https://www.ncbi.nlm.nih.gov/pubmed/35690149 http://dx.doi.org/10.1016/j.gie.2022.05.023 |
Ejemplares similares
-
Implementation and Impact of Universal Preprocedure Testing of Patients for COVID-19 Before Endoscopy
por: Podboy, Alexander, et al.
Publicado: (2020) -
Outcomes of Universal Preprocedure Coronavirus Disease 2019 Testing Before Endoscopy in a Tertiary Care Center in New York City
por: Dolinger, Michael T., et al.
Publicado: (2020) -
The Importance of Universal Preprocedural Testing for the Novel Coronavirus 2019
por: Zhang, Felicia, et al.
Publicado: (2020) -
Preprocedural COVID-19 Testing for High Risk Procedures
por: Palaniswamy, Haritha, et al.
Publicado: (2021) -
COVID-19: Impact on Endoscopy and GI Community
por: Maselli, Roberta
Publicado: (2021)